Vimarsana
Biggest News Aggregation in the World

Page 5 - Simon Latimer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Simon Latimer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Simon Latimer Today - Breaking & Trending Today

Whistleblower replaced on FINA Technical Committee, Zhou remains Bureau Liaison - Vimarsana News

Whistleblower replaced on FINA Technical Committee, Zhou remains Bureau Liaison

Whistleblower Simon Latimer, who reported International Swimming Federation vice-president Zhou Jihong for misconduct at the Tokyo 2020 Olympic Games, has been replaced on the updated Technical Diving Committee.

Official, Whistleblower Speak Out On Allegations Against FINA VP Zhou Jihong - Vimarsana News

Official, Whistleblower Speak Out On Allegations Against FINA VP Zhou Jihong

Diving official Lisa Wright and whistleblower Simon Latimer revealed more details on Zhou this week in a report from CNN Sport.

Whistleblower Alleges FINA Vice President Behaved Unethically At Tokyo 2020 - Vimarsana News

Whistleblower Alleges FINA Vice President Behaved Unethically At Tokyo 2020

A whistleblower complaint alleges FINA Vice President Zhou Jihong has used her power to try and manipulate diving results.

Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that on April 8, 2022, the Human Capital Management and Compensation Committee of Ligand’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 40,000 shares of its common stock...

Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript - Vimarsana News

Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript

Operator Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Call. At this time all participants are in a listen-only mode. After the speaker's presentation there will be a question and answer session. [Operator Instructions] I would now like to hand the conference over to your first speaker today the Head of Investor Relations, Mr. Simon Latimer. Please go ahead sir. Simon Latimer -- Head of Investor Relations Thank you. Welcome to Ligand's second quarter of 2021 financial results and business update conference call. Our speakers for today's...

Source: fool.com